Blood esinophils, FeNO, and the modifiable risk of asthma attacks
Recorded webinar
In Sanofi’s RespTalks webinar in January, Professor Ian Pavord & Dr. Simon Couillard discussed the concept of treatable traits as a new approach to managing asthma. In this recording, we hear Dr. Couillard presenting his views on how the treatable traits approach can aid the management of severe asthma.
.jpg/jcr:content/1607733024-ddb89e53704a97b213bb4d47eaec9440c380d160ed7b663830de6a32a4cd3df5-d%20(1).jpg)
Speaker: Simon Couillard, MD
Simon Couillard, MD, is a Canadian specialist in respiratory medicine and a clinical teacher at the Université de Sherbooke. He finished a two-year clinical research fellowship in severe asthma with the University of Oxford under the supervision of Professor Pavord, and has started a joint Oxford-Leiden PhD on risk prediction in asthma.
Previously broadcast RespTalks
Resptalks is a series of scientific webinars & podcasts on current topics related to respiratory diseases such as asthma, chronic rhinosinusitis with nasal polyps, to type 2 inflammation and much more.
Om deze pagina te kunnen lezen, moet u ingelogd zijn. Als u nog geen account heeft, kunt u er hier een aanmaken.
.png/jcr:content/jcr_content%20(55).png)
-(3).jpg/jcr:content/jcr_content%20(3)%20(3).jpg)
Bevestig uw status
Bevestig uw status
Sanofi biedt u exclusieve content over onze verschillende therapeutische gebieden op één portal
speciaal voor professionals in de gezondheidszorg, inclusief wetenschappelijk nieuws, een ljst met
evenementen en tools en diensten voor uw dagelijkse praktik.